Sign in

CIK 0000318154 · Large accelerated filer

Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
953540776
Phone
(805)447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 4 Shares withheld for taxes VP, Finance & CAO gave up 17 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chairman, CEO and President gave up 2,282 shares (to pay taxes)
  3. DEFA14A Proxy Proxy Materials
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. ARS Other Annual Report to Security Holders
  8. UPLOAD Other SEC-generated Letter
  9. 4 Shares withheld for taxes EVP, Operations gave up 6,137 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP & Chief Technology Officer gave up 6,202 shares (to pay taxes)
  11. 4 Shares withheld for taxes SVP, Human Resources gave up 475 shares (to pay taxes)
  12. 4 Shares withheld for taxes SVP, Business Development gave up 438 shares (to pay taxes)
  13. 4 Shares withheld for taxes SVP & CCO gave up 703 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP & CFO gave up 5,168 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP & Gen. Counsel & Secy. gave up 5,879 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP, Global Commercial Ops gave up 6,461 shares (to pay taxes)
  17. 4 Shares withheld for taxes VP, Finance & CAO gave up 146 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chairman, CEO and President gave up 20,560 shares (to pay taxes)
  19. 4 Grant or award EVP, Operations acquired 12,278 shares (grant or award)
  20. 4 Grant or award EVP & Chief Technology Officer acquired 12,407 shares (grant or award)

Page 17 of 161 · 3,201 filings